LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis
In conclusion, LINC00200 may recruit E2F1 to the RAD51 recombinase (RAD51) promoter region, thereby up-regulating the expression of RAD51 and enhancing the chemoresistance of GC cells to Oxa. Our data suggested that LINC00200 could probably be a promising target for treating GC.
Source: Human Cell - Category: Cytology Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Study